Patent details

Basic Information

Publication number:

EP2447359

PCT Application Number:

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP121505259

PCT Publication Number:

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

Gene defects and mutant ALK kinase in human solid tumors

French Title of Invention:

Défauts de gène et ALK kinase mutante dans des tumeurs solides humaines

German Title of Invention:

Gendefekte und mutierte ALK-Kinase in festen menschlichen Tumoren

SPC Number:

Dates

Filing date:

13/04/2007

Grant date:

04/11/2015

EP Publication Date:

04/11/2015

PCT Publication Date:

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

02/05/2012

EP B1 Publication Date:

04/11/2015

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

13/04/2016

Expiration date:

13/04/2027

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

13/04/2007

 

 

Name:

Cell Signaling Technology Inc.

Address:

3 Trask Lane, Danvers MA 01923, United States (US)

Inventor

1

Name:

Rikova Klarisa

Address:

United States (US)

2

Name:

Yu Jian

Address:

United States (US)

3

Name:

Guo Ailan

Address:

United States (US)

4

Name:

Sullivan Laura

Address:

United States (US)

5

Name:

Gu Ting-lei

Address:

United States (US)

6

Name:

MacNeil Joan

Address:

United States (US)

7

Name:

Possemato Anthony

Address:

United States (US)

8

Name:

Haack Herbert

Address:

United States (US)

Priority

Priority Number:

792364 P

Priority Date:

14/04/2006

Priority Country:

United States (US)

Classification

Main IPC Class:

C12N 9/12;

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages